HIMS
Get informed when a big investor buys or sells
+ FollowUndervalued by 243.3% based on the discounted cash flow analysis.
| Market cap | $6.47 Billion |
|---|---|
| Enterprise Value | $7.55 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.57 |
| Beta | 2.41 |
| Outstanding Shares | 231,746,126 |
| P/E Ratio | -47.54 |
|---|---|
| PEG | 15.69 |
| Price to Sales | 2.64 |
| Price to Book Ratio | 29.0 |
| Enterprise Value to Revenue | 2.93 |
| Enterprise Value to EBIT | -96.11 |
| Enterprise Value to Net Income | -54 |
| Total Debt to Enterprise | 0.22 |
| Debt to Equity | 5.21 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.7482▼ 4.50% |
|---|---|
| Total Calls | 36,999,234▲ 3.11% |
| Total Puts | 27,684,034▼ 2.74% |
Holdings and activity of institutional investors.
| Ownership % | 69.34%▲ 3.93% |
|---|---|
| Total Invested | $5.48B▲ 76.90% |
| Investors Holding | 586▲ 96.00% |
No data
Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermato...